Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OX40 is a potent immune-stimulating target in late-stage cancer patients.
Curti BD, Kovacsovics-Bankowski M, Morris N, Walker E, Chisholm L, Floyd K, Walker J, Gonzalez I, Meeuwsen T, Fox BA, Moudgil T, Miller W, Haley D, Coffey T, Fisher B, Delanty-Miller L, Rymarchyk N, Kelly T, Crocenzi T, Bernstein E, Sanborn R, Urba WJ, Weinberg AD. Curti BD, et al. Among authors: weinberg ad. Cancer Res. 2013 Dec 15;73(24):7189-7198. doi: 10.1158/0008-5472.CAN-12-4174. Epub 2013 Oct 31. Cancer Res. 2013. PMID: 24177180 Free PMC article. Clinical Trial.
OX-40: life beyond the effector T cell stage.
Weinberg AD, Vella AT, Croft M. Weinberg AD, et al. Semin Immunol. 1998 Dec;10(6):471-80. doi: 10.1006/smim.1998.0146. Semin Immunol. 1998. PMID: 9826580 Review.
Examining the immune response in sentinel lymph nodes of mice and men.
Chu Y, Hu HM, Winter H, Wood WJ, Doran T, Lashley D, Bashey J, Schuster J, Wood J, Lowe BA, Vetto JT, Weinberg AD, Puri R, Smith JW 2nd, Urba WJ, Fox BA. Chu Y, et al. Among authors: weinberg ad. Eur J Nucl Med. 1999 Apr;26(4 Suppl):S50-3. doi: 10.1007/s002590050578. Eur J Nucl Med. 1999. PMID: 10199933
Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine development.
Meijer SL, Dols A, Hu HM, Jensen S, Poehlein CH, Chu Y, Winter H, Yamada J, Moudgil T, Wood WJ, Doran T, Justice L, Fisher B, Wisner P, Wood J, Vetto JT, Mehrotra R, Rosenheim S, Weinberg AD, Bright R, Walker E, Puri R, Smith JW 2nd, Urba WJ, Fox BA. Meijer SL, et al. Among authors: weinberg ad. J Clin Pharmacol. 2001 Jul;41(S7):81S-94S. J Clin Pharmacol. 2001. PMID: 11452734 Review. No abstract available.
296 results